🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Stéphanie Kovacs

Centers for Disease Control and Prevention

ORCID: 0000-0002-2171-821X

Also affiliated with University of Liège, AID Atlanta, Center for Global Health, Haute École Charlemagne, Centre Hospitalier Universitaire de Liège

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial”.

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00139-1
N/A
1.4DataRank · unranked
24 citations

Khalequ Zaman, Masuma Hoque, Concepción F. Estívariz, Cara C. Burns, Jennifer L. Konopka‐Anstadt +15 more

Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine

Vaccine(2022)10.1016/j.vaccine.2022.03.013
N/A
0.520DataRank · unranked
31 citations

Hil Lyons, Caroline S. Bennette, Stéphanie Kovacs, Jeevan K. Makam, John Vertefeuille +2 more

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial

Vaccine(2021)10.1016/j.vaccine.2021.08.065
N/A
0DataRank · unranked
9 citations

Stéphanie Kovacs, Kristin VanderEnde, Asma Binte Aziz, Mohammed Yunus, Sara Khan +7 more

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks

Vaccine(2022)10.1016/j.vaccine.2022.03.027
N/A
0DataRank · unranked
29 citations

Stéphanie Kovacs, Ondrej Mach, Concepción F. Estívariz